CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics Inc. (NASDAQ:MCRB), a leading microbiome therapeutics company, announced today that Roger Pomerantz, M.D., President, Chief Executive Officer and Chairman of Seres, will present a company overview at the 34th annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place on Wednesday, Jan. 13, at 3 p.m. PT at the Westin St. Francis Hotel.
